Physician

Michael Drabkin, M.D.

According to 2025 Medicare claims, Michael Drabkin, M.D. (NPI: 1992048391) practices diagnostic radiology in the Nassau County-Suffolk County, NY market, with the plurality of this provider's patient population coming from Nassau, NY. This provider's primary affiliated billing organization is NORTH SHORE HEMATOLOGY ONCOLOGY ASSOCIATES PC (NPI: 1396794574; TIN: 112419534) and primary practice location at 11042-0001. Drabkin is affiliated with the ilumed, LLC (ACO ID: D0005), Physician Leaders Direct Contracting Entity, LLC (ACO ID: D0171), and Vytalize Health 9 ACO LLC (ACO ID: D0313), participating under the REACH model.

Drabkin's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 903 traditional Medicare patients, billed 6,100 HCPCS/CPT codes, and received $1,986,966 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 623 prescription claims across 228 beneficiaries totaling $3,651 in drug costs, led by Methylprednisolone (Methylprednisolone). Open Payments data shows 17 records totaling $2,877. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $38,253 to $1,986,966. Concurrently, this provider has fewer than 5 years of reported Part D prescription costs data, so a reliable trend cannot be assigned. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$993K$2.0M2020 Medicare payment: $38,253 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $126,564 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $691,501 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,235,264 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,986,966 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020258488$38,253
20217062,268$126,564
20226634,941$691,501
20237195,868$1,235,264
20249036,100$1,986,966

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.8K$3.7K2022 Drug cost: $650 (USD; Tot_Drug_Cst)2023 Drug cost: $1,845 (USD; Tot_Drug_Cst)2024 Drug cost: $3,651 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
20223464$650
202381214$1,845
2024228623$3,651

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more210323$159
38222Biopsy and aspiration of bone marrow sample for diagnosis201204$158
77012Review by radiologist of ct guidance for needle placement235239$124
36415Insertion of needle into vein for collection of blood sample426551$9
J0690Injection, cefazolin sodium, 500 mg218774$1

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
MethylprednisoloneMethylprednisolone1931,197$1,339
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst70462$803
Ciprofloxacin HclCiprofloxacin Hcl136950$649
NaproxenNaproxen132973$301
Oxybutynin ChlorideOxybutynin Chloride29290$178

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.17$2,877Medical Device Business Services, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Michael Drabkin, M.D.?

Tedicare shows public-source Medicare data for Michael Drabkin, M.D. (NPI 1992048391), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Michael Drabkin, M.D. have ACO affiliation data?

Michael Drabkin, M.D. is shown with ACO affiliation data for ilumed, LLC (REACH, ACO ID D0005), Physician Leaders Direct Contracting Entity, LLC (REACH, ACO ID D0171), and Vytalize Health 9 ACO LLC (REACH, ACO ID D0313).

What billing organization is linked to Michael Drabkin, M.D.?

Michael Drabkin, M.D. is linked to NORTH SHORE HEMATOLOGY ONCOLOGY ASSOCIATES PC (billing NPI 1396794574) in the available physician profile data.

Does Michael Drabkin, M.D. have Open Payments data?

Michael Drabkin, M.D. has 17 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.